» Articles » PMID: 31319150

Correlation Between the Stability Constant and PH for β-cyclodextrin Complexes

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2019 Jul 19
PMID 31319150
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In drug formulations, cyclodextrins are used to increase aqueous solubility and chemical stability of drugs via formation of inclusion complexes. For ionizable drug molecules, the complexation strength depends on pH. Increased ionization leads to a more soluble drug, but also results in destabilization of cyclodextrin complexes. Therefore, formulation scientists aim to find a balance between increased drug solubility and high complexation strength. In this work, a theoretical expression for the dependency between the stability constant and pH is presented, allowing the accurate prediction of the stability constant at any pH. The theoretical expression requires three out of four input parameters; the pK of the free guest molecule, the pK of the complex, and the stability constants for the neutral and fully ionized complex. Stability constants for β-cyclodextrin and ibuprofen complexes were determined by isothermal titration calorimetry at seven pH values (2.5-5.5) and four temperatures (15-55 °C). All these measured stability constants complied with the theoretical expression. Ten additional data sets from the literature comprising eight different drug molecules and three different cyclodextrins confirmed the ability of the theoretical expression to account for the observed pH-dependence of stability constants.

Citing Articles

Inclusion Complex of Clomiphene Citrate with Hydroxypropyl-β-Cyclodextrin for Intravenous Injection: Formulation and Stability Studies.

Annaji M, Mita N, Poudel I, Wang Q, Tipton B, Jayachandra Babu R AAPS PharmSciTech. 2023; 24(1):48.

PMID: 36702943 PMC: 9879620. DOI: 10.1208/s12249-023-02513-y.


Pharmaceutical Systems as a Strategy to Enhance the Stability of Oxytetracycline Hydrochloride Polymorphs in Solution.

Bueno M, Longhi M, Garnero C Pharmaceutics. 2023; 15(1).

PMID: 36678821 PMC: 9862800. DOI: 10.3390/pharmaceutics15010192.


Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: Modeling, Formulation, and Characterization.

Anjani Q, Dominguez-Robles J, Utomo E, Font M, Martinez-Oharriz M, Permana A Pharmaceuticals (Basel). 2022; 15(1).

PMID: 35056077 PMC: 8781390. DOI: 10.3390/ph15010020.


Ex Vivo and In Vivo Evaluation of Dodecaborate-Based Clusters Encapsulated in Ferumoxytol Nanoparticles.

Bernier N, Teh J, Reichel D, Zahorsky-Reeves J, Perez J, Spokoyny A Langmuir. 2021; 37(49):14500-14508.

PMID: 34843246 PMC: 8761388. DOI: 10.1021/acs.langmuir.1c02506.